Paolo Gattuso to Receptors, Estrogen
This is a "connection" page, showing publications Paolo Gattuso has written about Receptors, Estrogen.
Connection Strength
0.709
-
Prolylcarboxypeptidase promotes IGF1R/HER3 signaling and is a potential target to improve endocrine therapy response in estrogen receptor positive breast cancer. Cancer Biol Ther. 2022 Dec 31; 23(1):1-10.
Score: 0.207
-
Prognostic Markers and Histologic Subtypes in Patients with Meningeal Carcinomatosis in Breast Cancer. Acta Cytol. 2017; 61(2):140-144.
Score: 0.138
-
Prognostic Value of Coexisting Lobular Carcinoma In Situ With Invasive Lobular Carcinoma. Appl Immunohistochem Mol Morphol. 2016 Nov/Dec; 24(10):738-743.
Score: 0.135
-
Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma. Breast J. 2005 Jul-Aug; 11(4):278-80.
Score: 0.061
-
Assessment of Her-2/Neu status by immunohistochemistry and fluorescence in situ hybridization in mammary Paget disease and underlying carcinoma. Appl Immunohistochem Mol Morphol. 2003 Jun; 11(2):120-4.
Score: 0.053
-
Predictors of lymph node metastasis in T1 breast carcinoma, stratified by patient age. Breast J. 2002 Nov-Dec; 8(6):349-55.
Score: 0.051
-
Low-stage carcinoma of the male breast. A histologic, immunohistochemical, and flow cytometric comparison with localized female breast carcinoma. Am J Clin Pathol. 1999 Jan; 111(1):59-69.
Score: 0.039
-
The challenging estrogen receptor-negative/ progesterone receptor-negative/HER-2-negative patient: a promising candidate for epidermal growth factor receptor-targeted therapy? Breast J. 2006 Jul-Aug; 12(4):360-2.
Score: 0.016
-
Mucinous carcinoma of the eyelid. An immunohistochemical study. Am J Dermatopathol. 1995 Oct; 17(5):494-8.
Score: 0.008